Abstract:Background and Aims: Metastasis is the major cause of death in patients with colorectal carcinoma (CRC).Thyroid hormone receptor interacting protein 6 (TRIP6) is an adaptor protein that regulates cell motility and anti-apoptotic signaling.This study aimed to elucidate the biological function and molecular mechanism of TRIP6 in CRC metastasis.Methods: TRIP6 expression was assessed in 226 paired human CRC tumor and adjacent non-tumor tissues, and 15 paired primary and metastatic CRC by RT-qPCR and immunohistochemistry from our cohort, and validated in TCGA cohort (n=286).Function of TRIP6 in metastasis was studied in vitro and in vivo.TRIP6 related pathways were identified by RNA-sequencing, pathway luciferase reporter assays and western blot.Protein interaction of TRIP6 and its downstream effectors was identified by co-immunoprecipitation (co-IP).Colonic epithelial cell tight junction was assessed by transmission electron microscope (TEM).Results: TRIP6 mRNA and protein were significantly up-regulated in CRC tumors compared to adjacent normal tissues in our cohort I (n=150, P<0.0001) and cohort II (n=76, P<0.0001) of CRC primary patients, as well as in TCGA cohort (n=286, P<0.0001).A more pronounced TRIP6 expression was demonstrated in CRC liver metastasis lesions compared to primary CRC tissues (n=15, P<0.0001).TRIP6 disrupted the integrity of tight junction in CRC by directlyinteracting critical tight junction-associated PDZ domain-containing proteins (PARD3, ZO-1, ZO-3 and MAGI1) in colon cancer cell lines by co-IP and immunofluorescence staining.Ectopic expression of TRIP6 in colon cancer cell lines (DLD1 and SW480) significantly promoted cell migration and invasion ability in vitro (all P<0.01) through inducing EMTmetastasis genes.In keeping with the in vitro findings, ectopic expression of TRIP6 in SW480 cells promoted colorectal cancer liver metastasis in nude mice, along with disrupted colonic epithelial cell tight junction by TEM.Moreover, TRIP6 promoted colon cancer cells growth in liver microenvironment.The pro-metastatic effect by TRIP6 was depending on the tight junction-associated PDZ domain-containing protein.On the other hand, knockdown of TRIP6 in HCT116 and SW1116 cells inhibited cell migration ( P<0.01) and invasion (P<0.001)abilities and suppressed liver metastasis in nude mice compared to control group ( P<0.001).Mechanistically, TRIP6 activated AKT/HIF1a signaling as identified by RNA-sequencing and confirmed by increased hypoxia response element (HRE) reporter activity ( P<0.01), enhanced p-Akt and HIF1a and decreased PTEN protein expression.Conclusion: TRIP6 is commonly overexpressed in CRC and more pronounced in liver metastasis.TRIP6 promotes metastasis by directly targeting tight junction-associated proteins to disrupt colonic epithelial cell integrity and byactivating AKT/HIF1a cascade.

TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells

TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas

TRAP1 Chaperones the Metabolic Switch in Cancer

Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1

Point mutations of the mitochondrial chaperone TRAP1 affect its functions and pro-neoplastic activity.

The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation

Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer

Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism

Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer

New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments

TRAP1: a viable therapeutic target for future cancer treatments?

Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide

TRAP1 suppresses oral squamous cell carcinoma progression by reducing oxidative phosphorylation metabolism of Cancer-associated fibroblasts

Disulfide-mediated tetramerization of TRAP1 fosters its antioxidant and pro-neoplastic activities.

O-GlcNAcylation suppresses TRAP1 activity and promotes mitochondrial respiration

Modulating p-AMPK/mTOR Pathway of Mitochondrial Dysfunction Caused by MTERF1 Abnormal Expression in Colorectal Cancer Cells

Sa1172 TRIP6-DEPENDENT ACTIVATION OF AKT/HIF1A CASCADE PROMOTES COLORECTAL CANCER METASTASIS BY DISRUPTING THE INTEGRITY OF CELL TIGHT JUNCTIONS

Abstract 4597: RNA m1A methyltransferase TRMT61A induces MAPK/ERK signaling and is a therapeutic target in colorectal cancer

TR-107, An Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer Cells

The METTL3/TRAP1 axis as a key regulator of 5-fluorouracil chemosensitivity in colorectal cancer

TRAP1 Inhibition Increases Glutamine Synthetase Activity in Glutamine Auxotrophic Non-small Cell Lung Cancer Cells